Gaurav Chandra
Gaurav Chandra
Contributor, The Yuan

Gaurav Chandra is the chief operating officer of drug developer Enzolytics. He also runs a platform that uses AI to assess the effects of nutrition, genetics and gut microbiome on chronic medical diseases and infectious diseases. He is a strong proponent of AI's role in early drug discovery and development.

AI-Driven Diagnostics Transform Healthcare
In the pandemic’s wake, the world still faces massive challenges in detecting and diagnosing many life-threatening illnesses. Dr Gaurav Chandra explores the evolution of healthcare from reactivity to prevention, prediction, participation, and personalization, along with the part that artificial intelligence-driven diagnostics has played in this transformation.
Gaurav Chandra  |  Apr 04, 2022
The Yuan AI 2022 - To Infinity and Beyond
New Era
Dr Gaurav Chandra presents the second in a series of articles this week on The Yuan platform predicting the evolution of artificial intelligence in 2022. He looks forward to what the future holds for us next year and explores five trends in AI that will shape humankind forever.
Gaurav Chandra  |  Dec 28, 2021
AI Provides Key to Pandemic Preparedness
The world appears to be on the cusp of monumental transformation in healthcare, thanks in no small part to COVID-19 which has provided a platform for the Fourth Industrial Revolution. Dr Gaurav Chandra believes this is an ideal opportunity for humanity to come together, work on tangible solutions to free us of this pandemic, prevent another, and leave a legacy for future generations.
Gaurav Chandra  |  Dec 20, 2021
Demystifying the Human Microbiome Using AI
Artificial Intelligence continues to be a significant driver for advancing healthcare and understanding the microbiome will be pivotal to that transformation. Dr Gaurav Chandra discusses the crucial role the microbiome will play, enabling precision medicine that is more preventive, predictive, and personal than ever before.
Gaurav Chandra  |  Dec 01, 2021